US equities |
MU $877.55 ▲+2.46% NVDA $210.96 ▼-0.59% SPCX $147.49 ▲+1.89% AAPL $347.73 ▼-0.14% TSLA $372.22 ▼-0.63% SNDK $1,238.03 ▼-1.82% META $642.62 ▼-0.96% AMD $516.79 ▲+1.74%
FinancialContent

Nyxoah SA - Ordinary Shares (NQ:NYXH)

0.8344 +0.0124 (+1.51%)
Delayed Quote Updated: 4:00 PM EDT, Oct 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Nyxoah SA - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Nyxoah Announces Preliminary Results for the Third Quarter of 2026 and Adjusts Revenue Guidance for 2026
From Nyxoah
Via GlobeNewswire
News headline image
Full 12-Month Data from the ACCCESS U.S. Pivotal Study in Complete Concentric Collapse Patients Presented at ISSS 2026
From Nyxoah
Via GlobeNewswire
News headline image
Nyxoah Appoints Liam Kelly as Chief Executive Officer
From Nyxoah
Via GlobeNewswire
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
News headline image
Nyxoah Announces Chief Financial Officer Transition
From Nyxoah
Via GlobeNewswire
News headline image
Nyxoah Announces First Patient Implanted in BREATHE, the U.S. Post-Approval Study of the Genio® System
From Nyxoah
Via GlobeNewswire
The trading volume of these stocks is deviating from the norm in today's session. ↗
Via Chartmill
Gapping stocks in Thursday's session ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Gainers Gelteq (NASDAQ:GELS) stock moved upwards by 20.3% to $0.84 during Wednesday's after-market session. The company's market cap stands at $5.6 million. Nyxoah (NASDAQ:NYXH) shares increased by... 
Via Benzinga
News headline image
Nyxoah Announces ACCCESS U.S. Pivotal Study Meets Primary Safety and Efficacy Endpoints in Complete Concentric Collapse Patients
From Nyxoah
Via GlobeNewswire
News headline image
Information on the total number of voting rights and shares
From Nyxoah
Via GlobeNewswire
News headline image
Nyxoah Q2 Earnings Call Highlights ↗
Nyxoah (NASDAQ:NYXH) reported second-quarter worldwide net revenue of €7.7 million, up 21% sequentially from the first quarter, as its U.S. commercial launch continued to expand. U.S. net revenue... 
Via MarketBeat
Topics Earnings
News headline image
Nyxoah Reports Second Quarter and First Half 2026 Financial and Operating Results
From Nyxoah
Via GlobeNewswire
News headline image
Nyxoah to Release Second Quarter 2026 Financial Results on August 5, 2026
From Nyxoah
Via GlobeNewswire
News headline image
Nyxoah Touts Genio U.S. Launch Traction, Reimbursement Stability at Investor Day ↗
Nyxoah (NASDAQ:NYXH) used its investor day presentation to outline early U.S. launch progress for its Genio hypoglossal nerve stimulation system, address reimbursement questions and describe its path... 
Via MarketBeat
News headline image
Nyxoah Announces Preliminary Results for the Second Quarter of 2026
From Nyxoah
Via GlobeNewswire
News headline image
Information on the total number of voting rights and shares
From Nyxoah
Via GlobeNewswire
News headline image
Publication relating to transparency notifications
From Nyxoah
Via GlobeNewswire
News headline image
Nyxoah to Host Investor Day in New York on July 8, 2026
From Nyxoah
Via GlobeNewswire
News headline image
Invitation to attend the extraordinary shareholders’ meeting of the Company to be held on July 9, 2026
From Nyxoah
Via GlobeNewswire
News headline image
Publication relating to transparency notifications
From Nyxoah
Via GlobeNewswire
News headline image
Nyxoah Receives $15 Million from the European Investment Bank
From Nyxoah
Via GlobeNewswire
News headline image
Nyxoah’s Genio® Wins Prix Galien UK 2026 Award for Best Medical Technology
From Nyxoah
Via GlobeNewswire
News headline image
Information on the total number of voting rights and shares
From Nyxoah
Via GlobeNewswire
News headline image
$110 Million in Aggregate Financings to Accelerate Genio's U.S. Commercial Launch
From Nyxoah
Via GlobeNewswire
News headline image
Nyxoah Announces Closing of Underwritten Public Offering
From Nyxoah
Via GlobeNewswire
News headline image
Nyxoah Announces Pricing of $95 Million Underwritten Public Offering
From Nyxoah
Via GlobeNewswire
News headline image
Nyxoah Announces Proposed Offering of Ordinary Shares
From Nyxoah
Via GlobeNewswire
News headline image
Nyxoah Enters New Chapter of Long Term Value Creation
From Nyxoah
Via GlobeNewswire
News headline image
Information on the total number of voting rights and shares
From Nyxoah
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >